Type 2 diabetes - controlling hyperglycaemia with early insulin use

Area of Science:

• Endocrinology
• Primary Care Medicine
• Diabetes Management

Background:

• Type 2 diabetes management frequently necessitates insulin initiation.
• Oral glucose-lowering therapies may fail to achieve adequate glycemic control.
• Progression to insulin is a common step in managing type 2 diabetes.

Purpose of the Study:

• To provide guidance on the timing and methods for initiating insulin therapy.
• Focus on the primary care setting for type 2 diabetes patients.
• Optimize glycemic control in patients with type 2 diabetes.

Main Methods:

• Review of current clinical guidelines and evidence.
• Focus on patient profiles requiring insulin.
• Consideration of maximal tolerated oral antihyperglycemic agent doses.

Main Results:

• Insulin initiation is generally recommended for HbA1c >7.0% over 3-6 months.
• Consideration for patients on maximal doses of metformin and sulfonylureas.
• Evidence supports specific insulin regimens.

Conclusions:

• Insulin therapy should be considered when glycemic targets are unmet with optimal oral agents.
• Australian guidelines suggest once-daily basal or premixed insulin.
• Timely insulin initiation improves type 2 diabetes outcomes.